Proof of Concept Trial

- A Four-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of AF-219 in Female Subjects with Interstitial Cystitis /Bladder Pain Syndrome

- Consist of four Phases

* Screening Phase: up to 14 days

* Baseline Assessment Phase: up to 7 days (must be at least 4 days but no longer than 7 days)

* Treatment Phase: 4 weeks

* Follow-Up Phase: 2 weeks

- Subject participation up to 9 weeks

About the Author

Leave a Comment